ME Therapeutics Secures US Patent, Advances Lead Programs
26 Sep 2025 //
BUSINESSWIRE
ME Therapeutics gets Backing for mRNA cancer, inflammatory Diseases
21 May 2025 //
BUSINESSWIRE
Azome Therapeutics Partners with NCATS to Research Inflammation
13 Nov 2024 //
PR NEWSWIRE